• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Gastrointestinal
  • Efficacy of Esomeprazole in Patients with Frequent Heartburn

Disease
gastroesophageal reflux disease
Drug Name
Nexium
Generic Name
esomeprazole
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
III
Start Date
Jan 18, 1971
Study Name
D961RC00002
Study Id
D961RC00002
ClinicalTrials.gov ID
NCT01370538
Recruiting Status
Closed
Protocol Status
Not Available
Report
Sep 12, 2012
  • D961RC00002.pdf (167 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013